FDA Denies Glucosamine, Chondroitin Osteoarthritis Qualified Health Claim
This article was originally published in The Tan Sheet
Executive Summary
FDA says there is "no credible scientific evidence" to support proposed health claims linking glucosamine and chondroitin to osteoarthritis (OA), joint degeneration (JD) and cartilage deterioration (CD)
You may also be interested in...
Rotta Sounds Off On FDA Rejection Of Glucosamine Claim
Rotta Pharmaceuticals says FDA made "errors" in its decision to reject a qualified health claim for glucosamine and osteoarthritis
Rotta Sounds Off On FDA Rejection Of Glucosamine Claim
Rotta Pharmaceuticals says FDA made "errors" in its decision to reject a qualified health claim for glucosamine and osteoarthritis
Rotta Sounds Off On FDA Rejection Of Glucosamine Claim
Rotta Pharmaceuticals says FDA made "errors" in its decision to reject a qualified health claim for glucosamine and osteoarthritis